Introducing Kalm Therapeutics (Kalm Tx): Pioneering a Breakthrough in Eczema Treatment
CFD Research is excited to announce the formation of Kalm Therapeutics (Kalm Tx) to bring a much-needed non-steroidal eczema treatment to patients with mild to moderate atopic dermatitis (~16M Americans).